This study aims to analyze the distribution of currently known causative (implicated in HL) variations in the SLC26A4 gene for the bioinformatic preselection of its potential regions that have the most significant diagnostic value for molecular testing in patients with HL. This evidence concerns the gene SLC26A4 and Hodgkins lymphoma.